Cara Therapeutics
CARA
$0.66
Share price
-4.20%
Change (1 day)
-84.22%
Change (1 year)
Categories
Cara Therapeutics (CARA) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $68.75 M
According to Cara Therapeutics 's latest financial reports the company's total liabilities are $68.75 M. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Cara Therapeutics - Total liabilities on balance sheet (from 2012 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | $68.75 M | 193.12% |
| 2022-12-31 | $23.45 M | 20.09% |
| 2021-12-31 | $19.53 M | -11.83% |
| 2020-12-31 | $22.15 M | -52.09% |
| 2019-12-31 | $46.24 M | -19.14% |
| 2018-12-31 | $57.19 M | 459.4% |
| 2017-12-31 | $10.22 M | -21.97% |
| 2016-12-31 | $13.1 M | 123.87% |
| 2015-12-31 | $5.85 M | 37.01% |
| 2014-12-31 | $4.27 M | -35% |
| 2013-12-31 | $6.57 M | 112.14% |
| 2012-12-31 | $3.09 M | -32.37% |
| 2011-12-31 | $4.58 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $98.78 B | 143,567.01% | 🇺🇸 USA |
 Pfizer PFE | $137.21 B | 199,456.42% | 🇺🇸 USA |
 Trevena TRVN | $41.58 M | -39.52% | 🇺🇸 USA |
 Acorda Therapeutics
ACOR | $0.30 B | 347.05% | 🇺🇸 USA |
 AcelRx Pharmaceuticals
ACRX | $6.29 M | -90.85% | 🇺🇸 USA |